HealthEquity (HQY) Reports In-Line Q3 EPS, FY EPS Guidances Misses Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Tech drags S&P 500, Nasdaq lower as Iran tensions, Nvidia earnings loom
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Tech drags S&P 500, Nasdaq lower as Iran tensions, Nvidia earnings loom
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
- Funds sell $44bn in semiconductors on AI concerns
Raymond James Downgrades HealthEquity, Inc (HQY) to Outperform
December 7, 2021 7:14 AM ESTRaymond James analyst C. Gregory Peters downgraded HealthEquity, Inc (NASDAQ: HQY) from Strong Buy to Outperform with a price target of $70.00 (from $90.00) following results.
The analyst commented, "The stock was down over 20% after hours last night as management lowered guidance (see page 2 for changes in guidance) for FY22 due in part to disappointing Service and Interchange revenue results. Service revenue declined 1.7% y/y to $103M in... More
